CRBU Latest Press Releases

-- December 1, 2025 --

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 Globe Newswire 4:05 PM

-- November 12, 2025 --

Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- November 3, 2025 --

Caribou Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 5:15 PM

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma Globe Newswire 7:00 AM

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies Globe Newswire 7:00 AM

-- November 2, 2025 --

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma Globe Newswire 4:00 PM

-- August 25, 2025 --

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference Globe Newswire 4:05 PM

-- August 12, 2025 --

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- July 25, 2025 --

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm Globe Newswire 7:35 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software